Functionally running a company during a pandemic comes with a laundry list of challenges. Many businesses find themselves at a crossroads, attempting to determine how to guarantee the health and safety of employees without compromising productivity.
With nationwide vaccine access slowly becoming a reality, SaaS companies have increasingly started launching software to help businesses navigate the current work climate with ease. Features range, depending on the software, and cater to different industry verticals. The consistency lies, however, in providing employers and healthcare professionals alike with management resources for solving and analyzing COVID-19-related problems.
Much of the software being developed so far is purposed for hospital staff. Companies like Microsoft, Phreesia, and Meditech have aimed their focus at providing healthcare professionals and clinics with the proper resources to monitor incoming vaccine shipments, maximize the reachability of vaccination events, and ensure equity in public distribution. These programs, which have previously only been available to the first recipients of the Pfizer and Moderna vaccines, will soon expand to housing influxes of immunization records and COVID-19 data globally.
Many SaaS companies have also taken the reins by offering modern technology for analyzing statistics and ensuring safety in the workplace. Workday, for instance, just announced its COVID-19 vaccine management software in mid-January, with the hopes that it will be utilized by the entirety of its 45-million-person database of employees. The goal of this software is to help employees safely re-enter the workplace by helping employers access risk factors based on exposure information and by using employee-reported vaccination data to give insight in potential herd-immunity.
Similarly, companies like VaxAtlas and Salesforce are providing information about vaccine safety, offering resources for scheduling immunizations locally, and utilizing reminders for employees to get their second administrations of the vaccine.
To date, there are dozens of companies that are integrating software to combat coronavirus risks in the workplace and beyond. Though normality seems like a pipedream in the current state of affairs, the implementation of said software might be the key. As many companies jump on the bandwagon, the focus remains unified: with the right finesse, technology will become the primary guide through the financial and social landscape of the world in these uncertain times.
